OncoSec Medical Incorporated Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Details Narrative)

Stock-Based Compensation (Details Narrative) - USD ($)					1 Months Ended			3 Months Ended		9 Months Ended
Stock-Based Compensation (Details Narrative) - USD ($)	Oct. 29, 2018	Oct. 26, 2018	Oct. 23, 2018	Aug. 22, 2018	Apr. 30, 2019	Dec. 31, 2018	Oct. 31, 2018	Apr. 30, 2019	Apr. 30, 2018	Apr. 30, 2019	Apr. 30, 2018
Purchase price of incentive stock options as a percentage of its fair value										85.00%
Number of stock options cancelled										206,113
Options granted to purchase shares										273,850
Term of stock options										1 year 4 months 24 days
Exercise price										$ 8.40
Intrinsic value of options outstanding					$ 0			$ 0		$ 0
Intrinsic value of options exercisable					0			0		0
Unrecognized stock-based compensation expenses					$ 2,500,000			$ 2,500,000		$ 2,500,000
Weighted-average grant date fair value of stock options granted								$ 4.00	$ 11.00	$ 5.70	$ 12.40
Number of shares issued for service, value								$ 211,896	$ 600,400	$ 657,504	$ 1,443,650
Shares available for grant					99,464			99,464		99,464
Research And Development Expense [Member]
Stock-based compensation costs								$ 200,000	400,000	$ 1,100,000	700,000
General And Administrative Expense [Member]
Stock-based compensation costs								400,000	1,500,000	1,500,000	3,800,000
Restricted Stock Units (RSUs) [Member]
Stock-based compensation costs								$ 100,000	$ 1,100,000	$ 500,000	$ 1,400,000
Options granted to purchase shares							5,000
Exercise price							$ 16.40
Number of granted shares vested	1,250	2,500					3,750
Number of shares vesting, description		The Company's Board of Directors approved the accelerated vesting of 25% of the outstanding restricted stock units (RSUs) held by the employee. The RSUs, which originally vest on the third anniversary of the grant date, or March 29, 2020, were accelerated to vest on October 26, 2018.
Number of shares vesting percentage		25.00%
Modification of accrued expense on unvested stock units		$ 63,278
Fair value of vested stock grants		$ 44,250
Number of restricted stock outstanding					88,114			88,114		88,114
Restricted Stock Units (RSUs) [Member] \| October 29, 2019 [Member]
Number of granted shares vested					1,250
Restricted Stock Units (RSUs) [Member] \| October 29, 2020 [Member]
Number of granted shares vested					1,250
Restricted Stock Units (RSUs) [Member] \| October 29, 2021 [Member]
Number of granted shares vested					1,250
Maximum [Member]
Maturity										6 years 6 months	6 years 6 months
Minimum [Member]
Maturity										5 years	5 years
Common Stock [Member]
Number of shares issued for service								15,300	32,358	48,000	79,859
Number of shares issued for service, value								$ 2	$ 3	$ 5	$ 8
Stock issued during period, shares, employee stock purchase plans									1,896	2,635	4,060
Individual [Member] \| Stock Option Cancellation Agreements [Member]
Number of stock options cancelled				30,000
Number of restricted stock issued				17,500
Stock-based compensation costs				$ 135,425
Two Consultants [Member] \| Stock Option Cancellation Agreements [Member]
Number of stock options cancelled			53,500
Stock-based compensation costs			$ 377,278
Employees [Member]
Options granted to purchase shares										20,000
Term of stock options										10 years
Vesting period of stock options granted										3 years
Exercise price										$ 16.40
Consultants [Member]
Stock-based compensation costs								$ 211,893	$ 600,400	$ 657,504	$ 1,443,650
Options granted to purchase shares										50,000
Term of stock options										10 years
Number of shares issued for service								15,300	32,357	48,000	79,859
Number of shares issued for service, value								$ 212,910	$ 600,400	$ 669,240	$ 1,443,650
Consultants [Member] \| Maximum [Member]
Exercise price										$ 14.30
Consultants [Member] \| Minimum [Member]
Exercise price										$ 8.461
Mr. Daniel J. O'Connor [Member] \| Restricted Stock Units (RSUs) [Member]
Options granted to purchase shares						75,000
Exercise price						$ 6.00
Number of granted shares vested						6,250
Number of shares vesting, description						The units vest as follows: 6,250 units vested on April 30, 2019, and the remaining 68,750 units vest in equal quarterly installments of 6,250 units beginning on April 30, 2019 and ending on October 31, 2021.
Number of unit remaining available to vest						68,750
Mr. Daniel J. O'Connor [Member] \| Equal Quarterly Installments [Member] \| Restricted Stock Units (RSUs) [Member]
Number of unit remaining available to vest						6,250
Employees, Directors and Consultants [Member]
Stock-based compensation costs								600,000	$ 1,900,000	$ 2,600,000	$ 4,500,000
Board of Directors [Member] \| Restricted Stock Units (RSUs) [Member]
Stock-based compensation costs								$ 1,100,000
2011 Plan [Member]
Number of shares authorized for issuance to awards granted					100,000			100,000		100,000
Provisional percentage of outstanding stock owned by stockholders										10.00%
Number of stock options cancelled										206,115
Options granted to purchase shares										273,850
Exercise price										$ 8.40
2011 Plan [Member] \| Minimum [Member]
Purchase price of incentive stock options as a percentage of its fair value										100.00%
Exercise price as a percentage of fair value of common stock										110.00%
2011 Plan [Member] \| Common Stock [Member]
Number of shares authorized for issuance to awards granted					950,000			950,000		950,000
2011 Plan [Member] \| Common Stock [Member] \| Maximum [Member]
Maximum shares granted per fiscal year per individual										50,000
Stock option exercisable period										10 years
2011 Plan [Member] \| Employees, Directors and Consultants [Member]
Employee stock purchase program description										The 2011 Plan authorizes a total of 750,000 for issuance thereunder, and includes an automatic increase of the number of shares of common stock reserved thereunder on the first business day of each calendar year by the lesser of: (i) 3% of the shares of the Company's common stock outstanding as of the last day of the immediately preceding calendar year; (ii) 100,000 shares; or (iii) such lesser number of shares as determined by the Company's Board of Directors.
Number of shares authorized for issuance to awards granted					750,000			750,000		750,000
Percentage of shares of common stock outstanding					3.00%			3.00%		3.00%
2011 Plan [Member] \| Employees [Member]
Options granted to purchase shares										125,350	125,900
Term of stock options										10 years	10 years
Vesting period of stock options granted										3 years	3 years
2011 Plan [Member] \| Employees [Member] \| Maximum [Member]
Exercise price										$ 15.80	$ 18.60
2011 Plan [Member] \| Employees [Member] \| Minimum [Member]
Exercise price										$ 6.001	$ 9.20
2011 Plan [Member] \| Directors [Member]
Options granted to purchase shares										77,500	115,000
Term of stock options										10 years	10 years
Vesting period of stock options granted											1 year
2011 Plan [Member] \| Directors [Member] \| Maximum [Member]
Vesting period of stock options granted										3 years
Exercise price										$ 8.412	$ 19.40
2011 Plan [Member] \| Directors [Member] \| Minimum [Member]
Vesting period of stock options granted										1 year
Exercise price										$ 5.80	$ 9.79
2011 Plan [Member] \| Consultants [Member]
Options granted to purchase shares										1,000	70,500
Term of stock options										10 years	10 years
Exercise price										$ 6.254
2011 Plan [Member] \| Consultants [Member] \| Maximum [Member]
Exercise price											$ 18.80
2011 Plan [Member] \| Consultants [Member] \| Minimum [Member]
Exercise price											$ 10.00
2011 Plan [Member] \| Mr. Daniel J. O'Connor [Member]
Options granted to purchase shares											250,000
Vesting period of stock options granted											2 years
Number of granted shares vested											100,000
2011 Plan [Member] \| Mr. Daniel J. O'Connor [Member] \| Performance Stock Option Award [Member]
Options granted to purchase shares											25,000
2011 Plan [Member] \| Mr. Daniel J. O'Connor [Member] \| Tranche One [Member]
Options granted to purchase shares											100,000
2011 Plan [Member] \| Mr. Daniel J. O'Connor [Member] \| Tranche Two [Member] \| Performance Stock Option Award [Member]
Options granted to purchase shares											50,000
2011 Plan [Member] \| Mr. Daniel J. O'Connor [Member] \| Tranche Three [Member]
Options granted to purchase shares											25,000
ESPP [Member]
Stock-based compensation costs										$ 13,200	$ 16,300
Shares available for grant					39,661			39,661		39,661
Discount from market price, offering date										15.00%
Fair market value of unvested shares, percentage										15.00%
Maturity										6 months	6 months
Risk free interest rate										2.22%	1.15%
Volatility rate										61.83%	62.60%
Forfeitures percentage										0.00%	0.00%
Dividend										$ 0	$ 0
ESPP [Member] \| Six Month Call On The Unvested Share [Member]
Purchase price of incentive stock options as a percentage of its fair value										85.00%
ESPP [Member] \| January 31, 2019 [Member] \| Sixth Offering Period [Member]
Shares purchased										1,428
ESPP [Member] \| July 31, 2016 [Member] \| First Offering Period [Member]
Shares purchased										1,778
ESPP [Member] \| January 31, 2017 [Member] \| Second Offering Period [Member]
Shares purchased										1,863
ESPP [Member] \| July 31, 2017 [Member] \| Third Offering Period [Member]
Shares purchased										2,164
ESPP [Member] \| January 31, 2018 [Member] \| Fourth Offering Period [Member]
Shares purchased										1,896
ESPP [Member] \| July 31, 2018 [Member] \| Fifth Offering Period [Member]
Shares purchased										1,207